Mouthwash Temperature and Oral Mucositis in Head and Neck Radiotherapy
CoolRinseHNC
Effectiveness of Different Mouthwash Temperatures on Oral Mucositis Pain and Patient Comfort During Radiotherapy for Head and Neck Cancer: A Randomized Controlled Trial
1 other identifier
interventional
200
1 country
1
Brief Summary
This single-center randomized controlled trial evaluates the effects of cold (15-20°C) versus room-temperature (30-35°C) water gargling on oral mucositis severity, pain, and comfort in patients with head and neck cancer undergoing radiotherapy. Participants will rinse their mouth four times daily for 30-60 seconds over a 6-week radiotherapy course, with follow-up for two additional weeks. The study hypothesizes that cold-water rinsing can reduce the severity of radiation-induced oral mucositis (RTOM) and pain, improve oral comfort, and minimize treatment interruptions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
November 26, 2025
July 1, 2025
12 months
November 18, 2025
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Oral Mucositis Severity
Assessed using WHO Oral Mucositis Grading Scale (0-4).
Baseline (prior to radiotherapy), Week 2, Week 4, Week 6 (end of radiotherapy), and 2 weeks after completion of radiotherapy
Pain Intensity (VAS 0-10)
Patient-reported pain intensity using VAS (0-10).
Baseline (prior to radiotherapy), Weeks 1-6 during radiotherapy, and 2 weeks after completion of radiotherapy
Secondary Outcomes (3)
Oral Comfort
Baseline, Week 2, Week 4, Week 6 (end of radiotherapy)
Satisfaction with Rinsing Modality
Week 6 (end of radiotherapy) and 2 weeks after completion of radiotherapy
Psychological Distress
Baseline (prior to radiotherapy) and Week 6 (end of radiotherapy)
Study Arms (2)
Cold Water Rinse
EXPERIMENTALParticipants will rinse their mouth with cold water at approximately 15-20°C, four times daily for 30-60 seconds throughout six weeks of radiotherapy, followed by a two-week follow-up period.
Room Temperature Water Rinse
NO INTERVENTIONParticipants will rinse their mouth with room-temperature water at approximately 30-35°C, with identical frequency and duration as the experimental arm.
Interventions
rinse their mouth with cold water at approximately 15-20°C
Eligibility Criteria
You may qualify if:
- Histologically confirmed head and neck cancer (HNC) receiving radiotherapy for the first time, with or without concurrent chemotherapy.
- Conscious, communicative, and able to perform the rinsing procedure and complete questionnaires.
- Provided written informed consent prior to enrollment.
You may not qualify if:
- Non-HNC diagnoses or radiotherapy to sites outside the oral/oropharyngeal region.
- Cognitive impairment or inability to complete the rinsing protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chung Shan Medical University
Taichung, Taiwan (r.o.c.), Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2025
First Posted
November 26, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
November 26, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share